Table 3.

Specific Clonal Cytogenetic Rearrangements and the NQO1 Polymorphism

Cytogenetics No. of PatientsNo. (%) of Patients With
Wild-type AllelesHeterozygous Mutation Homozygous Mutation
Abnormal no. 5  13  8 (62)  2 (15)  3 (23)  
Abnormal no. 7 16  4 (25)  9 (56)  3 (19)  
Abnormal no. 5 & 7 16  9 (56)  6 (38)  1 (6)  
t(11q23) or t(21q22) 14  10 (71)  4 (29)  0   
inv(16) or t(15;17)  10 3 (30)  7 (70)  0   
t(9;22)  9  5 (56) 4 (44)  0   
Other abnormality  14  6 (43) 8 (57)  0   
Normal  15  8 (53)  6 (40) 1 (5)  
Total numbers  1073-150 53 (50)  46 (43) 8 (7) 
Cytogenetics No. of PatientsNo. (%) of Patients With
Wild-type AllelesHeterozygous Mutation Homozygous Mutation
Abnormal no. 5  13  8 (62)  2 (15)  3 (23)  
Abnormal no. 7 16  4 (25)  9 (56)  3 (19)  
Abnormal no. 5 & 7 16  9 (56)  6 (38)  1 (6)  
t(11q23) or t(21q22) 14  10 (71)  4 (29)  0   
inv(16) or t(15;17)  10 3 (30)  7 (70)  0   
t(9;22)  9  5 (56) 4 (44)  0   
Other abnormality  14  6 (43) 8 (57)  0   
Normal  15  8 (53)  6 (40) 1 (5)  
Total numbers  1073-150 53 (50)  46 (43) 8 (7) 
F3-150

Three of the 104 patients had complex karyotypes with 2 recurring abnormalities, and each is included twice in this table. Two had wild-type alleles for NQO1: an Hispanic man with t-AML had del(5q) and t(3;21), and a Caucasian woman with AML after MDS had abnormalities of no. 5 and 7 and t(11;16)(q23;p13). One patient was heterozygous for the NQO1 polymorphism: a Caucasian man with AML de novo had inv(16) and t(11;21)(q13;q22).

or Create an Account

Close Modal
Close Modal